CQBW251B2202 COPD MoA Study

• Research type

  Research Study

• Full title

  A randomized, subjects and investigator blinded, placebo controlled parallel group study to assess the mode of action of QBW251 in patients with Chronic Obstructive Pulmonary Disease (COPD)

• IRAS ID

  1003158

• Contact name

  Jadwiga Anna Wedzicha

• Contact email

  j.wedzicha@imperial.ac.uk

• Eudract number

  2019-000325-49

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  20/LO/0749

• Date of REC Opinion

  26 Jun 2020

• REC opinion

  Further Information Favourable Opinion